For coffee drinkers, the latest brain-health research offers an encouraging reason to keep the morning ritual—but the strongest association appears tied to moderation and caffeine. A long-running analysis of more than 131,000 adults found that people drinking roughly two to three cups of caffeinated coffee per day had lower dementia risk and modestly better cognitive performance than those reporting little or no caffeinated coffee. The study’s key finding emerged from dietary and health data tracked for as long as 43 years.
Published in JAMA, the research drew on the Nurses’ Health Study and the Health Professionals Follow-up Study, two major U.S. cohorts that repeatedly collected information about participants’ diets and health. The analysis included 86,606 women and 45,215 men who did not have dementia, Parkinson disease, or cancer when they entered the study. Over the follow-up period, 11,033 participants developed dementia.
The association was substantial but not evidence that coffee prevents dementia. Participants with the highest caffeinated-coffee intake had a dementia rate of 141 cases per 100,000 person-years, compared with 330 cases among those in the lowest intake group. After statistical adjustment, the highest-consumption group had a hazard ratio of 0.82, translating to an approximately 18 percent lower risk. They also reported less subjective cognitive decline, while testing in the Nurses’ Health Study pointed to modestly better performance on some objective measures.
The beverage comparison may be the most intriguing part of the findings. Decaffeinated coffee was not associated with lower dementia risk or stronger cognitive performance, whereas tea showed a broadly similar pattern, with the most favorable associations appearing around one to two cups per day. That contrast raises the possibility that caffeine—or another compound more common in caffeinated drinks—could be involved, although the researchers say further work is needed to identify the mechanism.
The apparent benefit also held across differing inherited levels of dementia risk. Lead author Yu Zhang said the results were similar among people with higher and lower genetic predispositions, suggesting that family history did not erase the association. Still, the study was observational: participants were not randomly assigned to drink coffee, so unmeasured lifestyle or health differences could contribute to the result.
That caution matters because the researchers describe the effect as one potentially useful piece of a much larger prevention puzzle, not a prescription for unlimited caffeine. Senior author Daniel Wang emphasized that the effect size was small and pointed to the many other ways people can protect cognitive health as they age. For now, the evidence supports a familiar, moderate coffee habit—but it does not turn decaf into a dementia treatment, or make caffeine a substitute for sleep, exercise, medical care, and a balanced diet.
